Patents by Inventor Benjamin A. Seigal

Benjamin A. Seigal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligosaccharide compositions and methods for producing thereof
    Patent number: 11584805
    Abstract: Described herein are methods for the production of oligosaccharides, including functionalized oligosaccharides, from one or more sugars, such as one or more monosaccharides, using polymeric and solid-supported catalysts containing acidic and ionic groups. Also provided are the oligosaccharide compositions, including functionalized oligosaccharide compositions, obtained using the methods.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: February 21, 2023
    Assignee: DSM Nutritional Products, LLC
    Inventors: John M. Geremia, Anastasia V. Lioubomirov, Scott Han, Benjamin A. Seigal, Alicia Landry, Kyle Sherry, Stephen Panos, Devin Churchman, Andrew O'Connor
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF
    Publication number: 20210002387
    Abstract: Described herein are methods for the production of oligosaccharides, including functionalized oligosaccharides, from one or more sugars, such as one or more monosaccharides, using polymeric and solid-supported catalysts containing acidic and ionic groups. Also provided are the oligosaccharide compositions, including functionalized oligosaccharide compositions, obtained using the methods.
    Type: Application
    Filed: June 25, 2020
    Publication date: January 7, 2021
    Inventors: John M. GEREMIA, Anastasia V. MURPHY, Scott HAN, Benjamin A. SEIGAL, Alicia LANDRY, Kyle SHERRY, Stephen PANOS, Devin CHURCHMAN, Andrew O'CONNOR
  • Oligosaccharide compositions and methods for producing thereof
    Patent number: 10752705
    Abstract: Described herein are methods for the production of oligosaccharides, including functionalized oligosaccharides, from one or more sugars, such as one or more monosaccharides, using polymeric and solid-supported catalysts containing acidic and ionic groups. Also provided are the oligosaccharide compositions, including functionalized oligosaccharide compositions, obtained using the methods.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: August 25, 2020
    Assignee: Cadena Bio, Inc.
    Inventors: John M. Geremia, Anastasia V. Murphy, Scott Han, Benjamin A. Seigal, Alicia Landry, Kyle Sherry, Stephen Panos, Devin Churchman, Andrew O'Connor
  • Macrocyclic compounds for modulating IL-17
    Patent number: 9284283
    Abstract: The invention relates generally to macrocyclic compounds of formula I and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of IL-17 and/or are useful in the treatment of medical conditions, such as inflammatory diseases and other IL-17-associated disorders.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: March 15, 2016
    Assignee: Ensemble Therapeutics Corporation
    Inventors: Michael Taylor, Nicholas K. Terrett, William H. Connors, Cheri Snedeker, Kelley C. Shortsleeves, Benjamin A. Seigal, Stephen P. Hale, Timothy F. Briggs, Frank G. Favaloro, Jr., Tyler J. Cipriani, Dingxue Yan, Sethu L. Alexander, Atli Thorarensen, Li Xing
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF
    Publication number: 20160007642
    Abstract: Described herein are methods for the production of oligosaccharides, including functionalized oligosaccharides, from one or more sugars, such as one or more monosaccharides, using polymeric and solid-supported catalysts containing acidic and ionic groups. Also provided are the oligosaccharide compositions, including functionalized oligosaccharide compositions, obtained using the methods.
    Type: Application
    Filed: July 9, 2015
    Publication date: January 14, 2016
    Applicant: MIDORI USA, INC.
    Inventors: John M. GEREMIA, Anastasia V. MURPHY, Scott HAN, Benjamin A. SEIGAL, Alicia LANDRY, Kyle SHERRY, Stephen PANOS, Devin CHURCHMAN, Andrew O'CONNOR
  • MACROCYCLIC COMPOUNDS FOR MODULATING IL-17
    Publication number: 20150005319
    Abstract: The invention relates generally to macrocyclic compounds of formula I and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of IL-17 and/or are useful in the treatment of medical conditions, such as inflammatory diseases and other IL-17-associated disorders.
    Type: Application
    Filed: February 1, 2013
    Publication date: January 1, 2015
    Inventors: Michael Taylor, Nicholas K. Terrett, William H. Connors, Cheri Snedeker, Kelley C. Shortsleeves, Benjamin A. Seigal, Stephen P. Hale, Timothy F. Briggs, Frank G. Favaloro, Jr., Tyler J. Cipriani, Dingxue Yan, Sethu L. Alexander, Atli Thorarensen, Li Xing
  • MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS
    Publication number: 20140135270
    Abstract: There are disclosed compounds that modulate the activity of inhibitors of apoptosis (IAPs), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
    Type: Application
    Filed: November 7, 2013
    Publication date: May 15, 2014
    Inventors: Robert M. Borzilleri, Yong Zhang, Michael M. Miller, Benjamin A. Seigal
  • Detection Assays and Use Thereof
    Publication number: 20100159446
    Abstract: The invention provides compositions and methods for the detection and/or quantification of biological targets (e.g., nucleic acids and proteins) by the nucleic acid-templated creation of one or more reaction products, for example, epitopes, enzyme substrates, enzyme activators, and ligands. The reaction products can be detected and/or quantitated after signal amplification using an amplification system.
    Type: Application
    Filed: July 21, 2008
    Publication date: June 24, 2010
    Inventors: Lawrence A. Haff, Yumei Huang, Richard A. Martinelli, Benjamin A. Seigal, David J. Livingston, Wei-Chuan Sun
  • MACROCYCLIC COMPOUNDS FOR INHIBITION OF TUMOR NECROSIS FACTOR ALPHA
    Publication number: 20100152099
    Abstract: The invention provides macrocyclic compounds and methods for their synthesis and use. In particular, the invention provides macrocyclic compounds that modulate the activity of tumor necrosis factor alpha and/or are useful in the treatment of medical conditions, such as, rheumatoid arthritis, psoriasis, and asthma.
    Type: Application
    Filed: August 20, 2009
    Publication date: June 17, 2010
    Inventors: Jinbo Lee, Julian F. Bond, Nicholas Terrett, Frank G. Favaloro, JR., Daniel Wang, Timothy F. Briggs, Benjamin A. Seigal, Wei-Chuan Sun, Stephen P. Hale